Pain Medicine Doctors in Marietta, GA Accepting Medicare

7 Pain Medicine doctors found. Showing 1 - 7

Dr. Quintin Gates, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-794-0477    Fax: 770-794-3108

Marvin D Tark, MD Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 400 Tower Road, Suite 350, Marietta, GA 30060 Phone: 770-590-1078    Fax: 770-422-7306

Thomas E Hurd, MD Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 400 Tower Road, Suite 350, Marietta, GA 30060 Phone: 770-590-1078    Fax: 770-422-7306

Victor Osisanya, M.D. Pain Medicine - Pain Medicine Medicare: Medicare Enrolled Practice Location: 2550 Windy Hill Rd Se Ste 215, Ste 215, Marietta, GA 30067 Phone: 770-850-8464    Fax: 770-850-9727

David W Gale, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Tower Rd Ne, Suite 350, Marietta, GA 30060 Phone: 770-590-1078    Fax: 770-422-7306

Babur Kilic, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-794-0477    Fax: 770-794-3108

Dr. George Joseph Schilling Iv, DO Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 620 Cherokee St Ne Ste 300, Marietta, GA 30060 Phone: 770-635-1812    Fax: 770-485-2883

News Archive

Cell therapies may stop or reverse pain and disability of degenerative disc disease

Cell therapies may stop or reverse the pain and disability of degenerative disc disease and the loss of material between vertebrae, according to Duke University scientists.

Matrix enters licensing agreement with Tibotec for generic Rilpivirine Hydrochloride

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.

Study provides insights into sexual health needs of bisexual teenage girls

Bisexual teenage girls are likely to miss out on the sexual healthcare information and services they need if healthcare providers present judgmental attitudes and assume patients' heterosexuality.

Trigger events for adopted adults

Regardless of whether adults adopted in infancy consider their adoptions to play an important role in their lives or not, certain "trigger events" in adulthood may result in a greater emphasis being placed on their adoptive status, new research from the University of Melbourne has found.

American Academy of Actuaries urge Senators to strengthen individual mandate in the health reform bill

The American Academy of Actuaries is urging senators to modify health care reform legislation released this week to contain stronger language regarding a health insurance individual coverage mandate. The actuaries said that an effective and enforceable mandate will minimize adverse selection stemming from more restrictive issue and rating rules prescribed by the bill.

Read more Medical News

› Verified 8 days ago